Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
John P MillerRoberta King

Abstract

The National Marrow Donor Program (NMDP) has been facilitating hematopoietic cell transplants since 1987. Volunteer donors listed on the NMDP Registry may be asked to donate either bone marrow (BM) or peripheral blood stem cells (PBSC); however, since 2003, the majority of donors (72% in 2007) have been asked to donate PBSC. From the donor's perspective these stem cell sources carry different recovery and safety profiles. The majority of BM and PBSC donors experienced symptoms during the course of their donation experience. Pain is the number 1 symptom for both groups of donors. BM donors most often reported pain at the collection site (82% back or hip pain) and anesthesia-related pain sites (33% throat pain; 17% post-anesthesia headache), whereas PBSC donors most often reported bone pain (97%) at various sites during filgrastim administration. Fatigue was the second most reported symptom by both BM and PBSC donors (59% and 70%, respectively). PBSC donors reported a median time to recovery of 1 week compared to a median time to recovery of 3 weeks for BM donors. Both BM and PBSC donors experienced transient changes in their WBC, platelet, and hemoglobin counts during the donation process, with most counts returning to baseline ...Continue Reading

Citations

Feb 20, 2013·International Journal of Hematology·Shu-Huey ChenKuo-Liang Yang
Jul 12, 2012·Expert Review of Hematology·Robert N Lown, Bronwen E Shaw
Dec 3, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Annelies BillenBronwen E Shaw
Jan 10, 2013·Medical Engineering & Physics·G J M TuijthofC Kment
Oct 16, 2012·Journal of the American College of Surgeons·Kristin M CookDavid H Livingston
Aug 10, 2010·Transplantation Proceedings·A Bosi, B Bartolozzi
Jun 28, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Bronwen E ShawMichael A Pulsipher
Aug 18, 2009·British Journal of Haematology·Derwood PamphilonSimon Stanworth
Feb 12, 2011·Journal of Clinical Apheresis·Daniel LysákPavel Jindra
Jul 14, 2012·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Jay S Reidler, Joshua Berkowitz
Sep 15, 2011·Journal of Clinical Apheresis·Betina Samuelsen SorensenBjarne Kuno Moller
Mar 26, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Linda J BurnsUNKNOWN Blood and Marrow Transplant Clinical Trials Network
Apr 23, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Maria C GarciaAllison Tong
Nov 5, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Galen E SwitzerJohn R Wingard
Apr 30, 2013·Journal of Plastic Surgery and Hand Surgery·Soh NishimotoMasao Kakibuchi
Oct 23, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Willis H NavarroMichael Pulsipher
Apr 27, 2016·Hematology/oncology Clinics of North America·Yen-Michael S Hsu, Melissa M Cushing
Dec 24, 2011·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·Rebecca Jill Vogel
May 13, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sandhya R PanchDavid F Stroncek
Nov 6, 2012·Nursing Ethics·Ann Begley, Susan Piggott
Aug 26, 2017·The Open Nursing Journal·Annika M Kisch, Anna Forsberg
May 31, 2018·The Open Nursing Journal·Annika M Kisch, Anna Forsberg
Apr 23, 2019·Annals of the New York Academy of Sciences·Evert-Jan F M de KruijfMelissa van Pel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.